XML 65 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
DEBT AND CREDIT FACILITIES (Tables)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
A summary of the Company’s debt obligations on its consolidated balance sheets is set forth below:
December 31, 2024December 31, 2023
Fair ValueCarrying ValueFair ValueCarrying Value
5.750% Senior Notes due 2033
$755,693 $742,068 $758,783 $741,124 
3.600% Senior Notes due 2029
376,816 396,051 371,276 395,137 
3.450% Senior Notes due 2027
290,070 298,765 283,350 298,270 
3.700% Senior Notes due 2025
299,550 299,908 293,154 299,537 
4.750% Senior Notes due 2025 (DaVinci) (1)
149,363 149,897 147,489 149,587 
Total senior notes1,871,492 1,886,689 1,854,052 1,883,655 
Medici Revolving Credit Facility (2)
— — 75,000 75,000 
Total debt$1,871,492 $1,886,689 $1,929,052 $1,958,655 
(1)    RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinci. Because RenaissanceRe controls a majority of DaVinci’s issued voting shares, the consolidated financial statements of DaVinci are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinci and RenaissanceRe’s financial exposure to DaVinci is limited to its investment in DaVinci’s shares and counterparty credit risk arising from reinsurance transactions.
(2)        RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici, and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions.
Schedule of Aggregate Amount of Maturities Related to the Company's Debt Obligations
The following table sets forth the scheduled maturity of the Company’s aggregate amount of its debt obligation reflected on its consolidated balance sheet at December 31, 2024:
2025$450,000 
2026— 
2027300,000 
2028— 
2029400,000 
After 2029750,000 
Unamortized discount and debt issuance expenses(13,311)
 $1,886,689 
  
Schedule of Credit Facilities
The outstanding amounts issued or drawn under each of the Company’s significant credit facilities is set forth below:
At December 31, 2024Issued or Drawn
Revolving Credit Facility (1)
$— 
Medici Revolving Credit Facility (2)
— 
Bilateral Letter of Credit Facilities
Secured
262,168 
Unsecured
357,443 
$619,611 
(1)At December 31, 2024, no amounts were issued or drawn under this facility.
(2)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici, and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions. The drawn amount of the Medici revolving credit facility is included on the Company’s consolidated balance sheets under debt.